7-amino-4-(6-bromo-7-hydroxybenzo[d]thiazol-2-yl)-2H-chromen-2-one

Names and Identifiers

Canonical SMILES: Nc1ccc2c(-c3nc4ccc(Br)c(O)c4s3)cc(=O)oc2c1

Standard InChI: InChI=1S/C16H9BrN2O3S/c17-10-3-4-11-15(14(10)21)23-16(19-11)9-6-13(20)22-12-5-7(18)1-2-8(9)12/h1-6,21H,18H2

Standard InChI Key: TWIVFRKGLZSGSC-UHFFFAOYSA-N

Molfile:

 
     RDKit          2D

 23 26  0  0  0  0  0  0  0  0999 V2000
    6.0334  -21.7857    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0322  -22.6053    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7403  -23.0142    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7385  -21.3769    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4471  -21.7821    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4505  -22.6073    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1629  -23.0147    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.8764  -22.6015    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8731  -21.7763    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1561  -21.3643    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5853  -23.0081    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.1501  -20.5458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8086  -20.0618    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    7.4864  -20.0691    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.7345  -19.2905    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5505  -19.2888    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9551  -18.5824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5450  -17.8773    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7259  -17.8830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3250  -18.5900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7723  -18.5796    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.9499  -17.1675    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    5.3242  -23.0133    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  5 10  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  8 11  2  0
 12 13  1  0
 13 16  1  0
 15 14  1  0
 14 12  2  0
 10 12  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
 17 21  1  0
 18 22  1  0
  2 23  1  0
M  END

Alternative Forms

Parent:

ALA4463514
---

Associated Targets(Human)

SNB-75 (44215 Activities)

Explore this target

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

OVCAR-4 (44535 Activities)

Explore this target

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

Molecule Features

Natural Product: No	Oral: No	Chemical Probe: No	Parenteral: No
Molecule Type: Unknown	Topical: No	First In Class: No	Black Box: No
Chirality: No	Availability: No	Prodrug: No

Drug Indications

MESH ID	MESH Heading	EFO IDs	EFO Terms	Max Phase for Indication	References

Mechanisms of Action

Mechanism of Action	Action Type	target ID	Target Name	Target Type	Target Organism	Binding Site Name	References

Calculated Properties

Molecular Weight: 389.23	Molecular Weight (Monoisotopic): 387.9517	AlogP: 4.12	#Rotatable Bonds: 1
Polar Surface Area: 89.35	Molecular Species: ACID	HBA: 6	HBD: 2
#RO5 Violations: ┄	HBA (Lipinski): 5	HBD (Lipinski): 3	#RO5 Violations (Lipinski): ┄
CX Acidic pKa: 6.32	CX Basic pKa: 2.75	CX LogP: 3.37	CX LogD: 2.30
Aromatic Rings: 4	Heavy Atoms: 23	QED Weighted: 0.38	Np Likeness Score: -0.46

References

1. Zhang L, Xu Z.. (2019) Coumarin-containing hybrids and their anticancer activities., 181 [PMID:31404864] [10.1016/j.ejmech.2019.111587]

Source

Source(1):

Scientific Literature